Boulder Medical Center
JUNE 12, 2024
What is your risk of having a major cardiovascular event such as a heart attack or stroke? Internist Logan Gladney, MD, shares tools that are used to assess heart disease. The post Dr. Logan Gladney: Heart Health Risk Assessment appeared first on Boulder Medical Center.
FDA Law Blog
JUNE 13, 2024
By Sara W. Koblitz — As we have noted for the last year or so, the FTC has been on a mission to clean up the Orange Book by removing what it deems to be “improper” patents. The FTC has put out policy statements, challenged patent listings, tapped Congress, appeared on talk shows, and filed amicus briefs all in the span of the last 8 months. It seems like all that work is paying off.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Clinical Problem Solvers
JUNE 8, 2024
[link] Episode 339: Neurology VMR – left facial numbness for 5 days We continue our campaign to #EndNeurophobia, with the help of Dr. Aaron Berkowitz. This time, Aye presents a case of left facial numbness for 5 days to Andrea and Sridhara. Neurology DDx Schema Aye Chan Moe Thant Aye graduated from University of Medicine, Mandalay, Myanmar, and has been working with her mentor neurologist, one of only three neurologists covering the Upper Myanmar region of 23 million population.
Evergreen Family Medicine
JUNE 11, 2024
Written By: Mary Powell, MD/OB/GYN Pelvic organ prolapse is a common condition that affects many women. It is estimated 1 out of 4 women in their 40s have some degree of prolapse. The prevalence increases as women age so much; that more women in their 80s have prolapse than do not. Prolapse literally means “to drop”. The pelvic organs (bladder, uterus with cervix, or bowel) can fall or drop out of their normal anatomical position.
PEMBlog
JUNE 10, 2024
Supraventricular tachycardia is really fun to convert. You go do all kinds of vagal maneuvers which are basically heart games. Then there’s the REVERT maneuver – it works great! Search for it and learn it. Or watch this video. Lyrics S V T! A heart rate so fast as fast as can be S V T! EKG super fast rate with no p waves Q R S is narrow, that’s what you will see S V T!
FDA Law Blog
JUNE 12, 2024
By Sara W. Koblitz & Jeffrey N. Gibbs — It’s been over a year and a half since Over-the-Counter (“OTC”) hearing aids became legal, and it’s not clear that they’ve made the difference in hearing loss treatment that Congress anticipated. (FDA once estimated that OTC hearing aids would save patients over $3000.) A recent GAO Report hasn’t found that OTC hearing aids have had much impact.
GeriPal
JUNE 13, 2024
Summary Transcript Summary I always find cachexia in serious illness puzzling. I feel like I recognize it when I see it, but I struggle to give a clear definition or provide effective ways to address it. In today’s podcast, we had the opportunity to learn from a renowned expert in palliative care, Eduardo Bruera, about cachexia and anorexia in serious illness.
Primary Care Digest brings together the best content for architecture professionals from the widest variety of industry thought leaders.
FDA Law Blog
JUNE 12, 2024
Hyman, Phelps & McNamara, P.C. (HP&M) seeks to add an experienced attorney (7+ years) to our government discount program and price reporting practice. Our ideal candidate will have significant substantive experience working with: Price calculation and reporting under the Medicaid Drug Rebate Program and the 340B Drug Discount Program Average sales price reporting under Medicare Part B Price reporting and contracting with the Department of Veterans Affairs Drug discounting requirements un
FDA Law Blog
JUNE 10, 2024
Last month the Department of Justice and the Drug Enforcement Administration submitted a notice of proposed rulemaking to reschedule cannabis from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. Hyman, Phelps & McNamara, P.C. Director Larry Houck will participate as a panelist focusing on this timely topic in the Food and Drug Law Institute’s (“FDLI’s”) “High Time for a Change: Implications of DEA’s Proposed Marijuana Rescheduling” webinar June 12, 2024, 2:00
FDA Law Blog
JUNE 10, 2024
By Larry K. Houck — It seems as though we cannot get through a week without hearing about controlled substance diversion by employees at another hospital or healthcare facility. We learned this week that Palomar Health, one of California’s largest healthcare districts, agreed to pay $250,000 to resolve allegations that numerous vials of fentanyl had been diverted from automated medication dispensing machines over a five-month period and that the hospital did not properly dispose of unused fentan
FDA Law Blog
JUNE 12, 2024
By Sarah Wicks & Charles D. Snow & James E. Valentine & Frank J. Sasinowski — Hyman, Phelps & McNamara (HPM) would like to congratulate the 7 rare disease programs selected for the inaugural class of the FDA’s “Support for clinical Trials Advancing Rare disease Treatment” (START) pilot program. The START pilot program was announced last September as a way to offer selected participants developing potentially life-saving and life-changing rare disease therapies enhanced communicat
Expert insights. Personalized for you.
130 
Let's personalize your content